1. Home
  2. R vs GRFS Comparison

R vs GRFS Comparison

Compare R & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryder System Inc.

R

Ryder System Inc.

HOLD

Current Price

$190.04

Market Cap

6.5B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.54

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
R
GRFS
Founded
1933
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.8B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
R
GRFS
Price
$190.04
$7.54
Analyst Decision
Buy
Hold
Analyst Count
10
2
Target Price
$214.44
$10.15
AVG Volume (30 Days)
281.8K
729.0K
Earning Date
04-22-2026
07-28-2022
Dividend Yield
1.89%
1.83%
EPS Growth
7.96
N/A
EPS
11.94
N/A
Revenue
$12,665,000,000.00
N/A
Revenue This Year
$3.91
$5.33
Revenue Next Year
$5.74
$6.50
P/E Ratio
$16.15
$18.67
Revenue Growth
0.23
N/A
52 Week Low
$125.54
$6.19
52 Week High
$230.39
$11.14

Technical Indicators

Market Signals
Indicator
R
GRFS
Relative Strength Index (RSI) 37.82 27.19
Support Level $184.78 N/A
Resistance Level $197.80 $9.11
Average True Range (ATR) 5.84 0.22
MACD -1.98 -0.08
Stochastic Oscillator 17.71 2.46

Price Performance

Historical Comparison
R
GRFS

About R Ryder System Inc.

Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: